ALVR106, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Treatment of Respiratory Viral Infections: Results from a Phase 1, First-in-Human, Dose-Ranging Trial

ALVR106 - Kalaris Therapeutics, Baylor College of Medicine

https://ashpublications.org/blood/article/142/Supplement1/6889/505285/ALVR106-an-Off-the-Shelf-Multivirus-Specific-T

Sarah Nikiforow; Mitchell Horwitz; John M. McCarty; Anum Abbas; James M. Coghill; Jenny Stanton; Julie Ma; Spyridoula Vasileiou; Sarah Gilmore; Bhagirathbhai Dholaria; Rabi Hanna; Randy Taplitz; Rajat Bansal

Dec 3, 2023